Article
A resource-based mechanistic framework for castration-resistant prostate cancer (CRPC)
2023-09-21
Abstract excerpt
Cancer therapy often leads to the selective elimination of drug-sensitive cells from the tumour. This can favour the growth of cells resistant to the therapeutic agent, ultimately causing a tumour relapse. Castration-resistant prostate cancer (CRPC) is a well-characterised instance of this phenomenon. In CRPC, after systemic androgen deprivation therapy (ADT), a subset of drug-resistant cancer cells autonomously p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5beb6ff9-05b6-5275-a2be-65d14651cd28
- DOI
- 10.1101/2023.09.19.558379
